{
    "title": "R40862",
    "content": "Medical malpractice insurance has been a topic of congressional attention during crisis periods in the mid-1970s, mid-1980s, and early 2000s due to sharp increases in premiums, difficulties in finding coverage, and physicians leaving areas. Public policy measures at state and federal levels have been implemented to address market disruptions, with the availability and premiums of medical liability insurance showing cyclical characteristics. The effectiveness of these measures remains a subject of debate. In the early 2000s, the debate focused on federal limits on the tort system to address insurance market disruptions. Studies show varying effects of state tort reforms on malpractice insurance premiums. The market for malpractice insurance in 2010 was described as 'soft' or 'flat' with most rates remaining stable. Total premiums for medical malpractice liability insurance decreased annually from 2006. Total premiums for medical malpractice liability insurance have decreased every year from 2006 to 2009. While the current market is not showing widespread signs of disruption, affordability issues still exist for certain specialties and regions. Physicians and groups are not reacting as strongly as in past crisis periods, with less public displays of dissatisfaction. However, equity and access issues persist in the malpractice system. The current interest in medical malpractice reform is driven by overall health reform and healthcare costs, rather than an immediate crisis in malpractice liability insurance. Congress may focus on how changes to the system affect the overall healthcare system, rather than just stabilizing premiums. Medical malpractice insurance adds relatively little to healthcare costs, with premiums totaling $10.8 billion in 2009. The total medical malpractice insurance premiums in 2009 were approximately $10.8 billion, while health expenditures were estimated at $2.6 trillion by CBO. Indirect costs, such as defensive medicine, have been controversial, with estimates suggesting they are higher than direct premiums. CBO's analysis indicated that federal tort reforms could reduce national health care spending by about 0.5% in 2009, equivalent to $11 billion. The CBO estimated that malpractice tort reforms could reduce health care spending by $41 billion from 2010 onwards. Studies have shown varying impacts of state tort reforms on health care spending, with reductions ranging from 3%-9%. Additionally, federal tort reforms could decrease national health care spending by about 0.5% in 2009, equivalent to $11 billion. The CBO estimated that tort reforms could reduce federal health care spending by $41 billion from 2010 to 2019, leading to an increase in federal revenues by $13 billion. Combining the impact on health spending and tax revenues, tort reforms could reduce the federal budget deficit by approximately $54 billion over 10 years. PPACA includes provisions encouraging states to develop litigation alternatives for medical malpractice while preserving individuals' right to seek redress in court. PPACA authorizes $50 million for a five-year period for the HHS Secretary to award demonstration grants to states for developing alternatives to current tort litigation for medical malpractice claims. States must create alternatives that resolve disputes caused by healthcare providers, promote patient safety data collection, and reduce healthcare errors. States must demonstrate the effectiveness of their alternative before receiving a grant. The 112th Congress has addressed health reform and medical malpractice issues by introducing H.R. 2, which aims to repeal P.L. 111-148. States seeking demonstration grants for alternatives to tort litigation must meet specific criteria to enhance patient safety and access to liability. H.R. 2, introduced by Representative Eric Cantor on January 5, 2011, aims to repeal P.L. 111-148. The House passed the bill on January 19, 2011. H.R. 5, the HEALTH Act of 2011, introduced by Representative Phil Gingrey on January 24, 2011, would impose national medical malpractice laws, preempting state laws with exceptions. The House Committee on the Judiciary marked up the bill on February 8 and 16, 2011. H.R. 5, the HEALTH Act of 2011, would impose national medical malpractice laws, setting limits on damages and attorneys fees while allowing states to maintain greater protections for healthcare providers. An amendment was adopted to eliminate a specific provision in the bill during a mark-up session on February 16, 2011. The amendment adopted during the mark-up of H.R. 5 eliminated provisions related to \"collateral source benefits\" in medical malpractice cases. Medical errors can lead to injury, which forms the basis of malpractice claims. Improving medical practices and penalizing poorly performing physicians may enhance the medical malpractice insurance system. The current state of the medical malpractice insurance system varies across states in terms of medical licensure, regulation, and patient safety strategies. States lack uniformity, financial resources, and clinical expertise to fully implement patient safety efforts. Federal involvement may include voluntary support for evidence-based medicine research and mandatory standards for institutional providers under Medicare. Reducing medical errors is a key goal. Medical malpractice insurance may not be significantly affected by addressing only patient safety concerns. Most malpractice claims are due to medical injuries not caused by negligence, and only a small number of patients file claims for negligent care. The complexity of the medical liability system and the practice of defensive medicine are key factors to consider when designing effective policies. Defensive medicine leads physicians to provide unnecessary healthcare services or avoid high-risk treatments to reduce liability. It is difficult to measure, and factors like payment systems and financial incentives may also contribute to over-provision of services. The tort system compensates for medical errors, but some argue it is not the sole cause of defensive medicine. Some argue that the medical malpractice tort system is inefficient in compensating for injuries and deterring errors. Valid claims may go unfiled, and outcomes can be arbitrary with significant variations in jury verdicts among states and counties. Medical malpractice reforms also contribute to this inconsistency. The medical malpractice tort system may result in higher non-economic damages for disabled high wage earners compared to non-wage earners. Data on tort outcomes are challenging to collect due to the lack of a central tracking source. Liability insurance shields physicians from the direct costs of malpractice, creating a buffer between awards and the physicians. Liability insurance for physicians spreads costs across a wide base, impacting a small number of physicians. Medical malpractice claims can take a long time to resolve, leading to uncertainty in estimating future claims and investment returns. This uncertainty may result in increased volatility in premiums. Medical malpractice liability insurance is regulated by individual states under the federal McCarran-Ferguson Act of 1945, resulting in variations in market structure and data availability. NAIC aggregates some insurance data, but significant data on closed claims is often not collected or made available. The cyclical experience of medical malpractice insurers is reflected in NAIC's industry data from 1992 to 1998. From 1992 to 1998, medical malpractice insurance losses remained stable, ranging from $3.18 billion to $4.46 billion. However, from 1998 to 2003, losses increased steadily, reaching $8.46 billion in 2003. Since then, losses have decreased annually, with 2009 seeing the lowest amount at $4.01 billion. Premiums have followed a similar trend but have not decreased as much as losses. The loss ratio, which compares losses to premiums, rose from 78.41% in 1997 to 126.83% in 2001, indicating lower profits for insurers. Since 2001, the medical malpractice insurance loss ratio has significantly decreased, with the lowest ratio in 2008 at 54.62% and the second lowest in 2009 at 55.66%. This led to the industry experiencing its highest profit margin in years. Insurers, regulated by state insurance regulators, may also profit or lose from investments. Despite low loss ratios, competition may not be increasing as expected due to insurers being cautious about past losses or depleted capital from the recent financial crisis."
}